Intelerad commits $75 Million to R&D for new AI and cloud-based medical imaging software solutions
Montreal, May 30, 2019 – For over 20 years, Intelerad Medical Systems™, a leader in enterprise workflows, has been contributing to higher efficiency and effectiveness for healthcare professionals while ensuring better care for patients. Today, Intelerad announced a $75 million investment in Research and Development to further that mission and extend its growing solutions portfolio.
“Medical imaging has undergone a significant transformation over the past 20 years, and Intelerad has been at the forefront of that evolution,” Mr. Paul Lepage, President and CEO of Intelerad said. “We are proud to support customers around the world in providing the highest standard of healthcare services.”
Well aware of the challenges facing health systems globally – namely patient engagement, access to care, performance and chronic disease management – Intelerad offers concrete solutions. “We will continue to make a difference in healthcare by delivering scalable, enterprise-wide medical imaging solutions for healthcare providers and their patients,” Lepage said.
On a daily basis, Intelerad solutions enable radiologists to perform more than 200,000 diagnostic interpretations worldwide. The company’s $75 million investment and ongoing focus on creating innovative, market-leading solutions for a global customer base is expected to fuel a twofold increase in study volume. Intelerad technology simplifies everyday tasks for radiologists and other healthcare professionals, enabling them to optimize efficiency and apply their expertise and energy toward more personalized services and follow-ups for every patient.
With an emphasis on cloud technology and artificial intelligence, Intelerad is focused on providing innovative Software as a Service (SaaS) solutions for healthcare. For example, the cloud-based Clairvoyance productivity dashboard will incorporate machine learning technology to provide predictive insights to imaging departments, enabling real-time, data-driven decisions that contribute to higher quality, more timely care and better outcomes for patients.
Over the last three years, Intelerad has expanded its employee base by 30%. The company expects to double in size over the next five years with the recruitment of additional subject matter experts and technologists to swiftly bring more innovative solutions to market, continue investing in customer satisfaction, and grow Intelerad’s presence worldwide.
“I’ve had the pleasure of using Intelerad technology in my daily work for 17 years, the company truly understands the needs of the medical imaging community,” said radiologist Dr. Giovanni Artho of the McGill University Health Centre (MUHC). “Intelerad solutions are highly versatile, extremely intuitive and constantly evolving to meet the needs of the market. They have a huge impact on efficiency and are critical for streamlining communication between care team members, which enables us to provide the highest quality patient care.”
For more information about Intelerad, please visit: Intelerad.com